Immix Biopharma - Rega Nyata Tumbas Perusahaan Kanthi Wutuh IMMX

immixbio.com (IMMX) - logo korporat

Immix Biopharma, Inc. (IMMX) is a leading developer of CAR-T therapies for the treatment of myeloma and autoimmune pathologies, possessing immense scientific potential. The company's environmental business strategy involves implementing "green chemistry" principles to minimize energy consumption and ensure the safe disposal of chemicals. The Enterprise Value price history is recorded at 436.26. Currently, the company's research capacities are fully utilized, and its production facilities are prepared to scale up drug manufacturing volumes.

IMMX (Immix Biopharma) riwayat Nilai Total Perusahaan saka 23.11.2025 nganti 28.10.2026

Immix Biopharma - rincian analitis lan metrik utama (IMMX)

- rega lan prakiraan konsensus rega:
Kutipan saham Immix Biopharma Inc.|IMMX - Bagan rega target
- data kapitalisasi pasar:
Biji pasar Immix Biopharma|IMMX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data kapitalisasi buku:
Ekuitas saben Saham Immix Biopharma|IMMX - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku immixbio.com|IMMX - Aset Agregat Perusahaan
- data utang lan likuiditas:
Rasio Utang marang Ekuitas Immix Biopharma, Inc.|IMMX - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Immix Biopharma Inc.|IMMX - Utang perusahaan|Utang-utang marang nilai buku Immix Biopharma|IMMX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Immix Biopharma
Pambiji fundamental:Immix Biopharma, Inc. (IMMX)
Produk asli Immix

The use of AI platforms and robotic screening in drug development optimizes costs for Immix Biopharma, Inc. (IMMX). The dynamics of the company's enterprise value (EV) reflect the actual acquisition price of the business. This metric sums market capitalization and debt, subtracting available cash. This allows for an asset valuation without distortions caused by reporting time lags. This indicator helps investors timely recognize stock overheating or fundamental shifts in the firm's value.

Pesaing Immix Biopharma, Inc. (IMMX)

ImmunityBio Inc - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|IMCR: Nilai Total Perusahaan|Janux Corp (JANX) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Arcus Biosciences, Inc.|ZYME (zymeworks.com) - Nilai Bisnis|Nilai Total Perusahaan TNGX (Tango Therapeutics, Inc.)|Total Nilai Perusahaan IOVA|Nilai Total Perusahaan Immatics Corp IMTX|Nilai Bisnis Xencor Inc. (XNCR)|Compass Therapeutics - Nilai Perusahaan|replimune.com - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|LYEL (Lyell Immunopharma, Inc.) - Nilai Total Perusahaan|IPHA: Total Nilai Perusahaan|pyxisoncology.com (PYXS) - Nilai Total Perusahaan|CGEN (Compugen) - Nilai Total Perusahaan|Nilai Total Perusahaan IOBT (IO Biotech, Inc.)|Total Nilai Perusahaan sutrobio.com|INKT: Nilai Perusahaan|Nilai Perusahaan Nalika Diakuisisi Penuh werewolftx.com HOWL|ALXO: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|CUE - Total Nilai Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh PDS Biotechnology Corp (PDSB)|SONN - Nilai Dipunlarasaken Utang lan Kas|MAIA Biotechnology, Inc. - Nilai Perusahaan|LIMN (Liminatus Pharma Inc.) - Rega Tumbas Perusahaan|Nilai Total Perusahaan LVTX|Rega Nyata Tumbas Perusahaan Kanthi Wutuh NXTC|Nilai Total Perusahaan LPTX (Leap Therapeutics, Inc.)|Rega Nyata Tumbas Perusahaan Kanthi Wutuh intensitytherapeutics.com INTS|Rega Nyata Tumbas Perusahaan Kanthi Wutuh SNSE (Sensei Biotherapeutics, Inc.)|Theriva Biologics Inc - Nilai Perusahaan|Gritstone Bio (GRTS) - Nilai Total Perusahaan|KA: Nilai Bisnis|Nilai Total Perusahaan NEXI|Total Nilai Perusahaan Turnstone Biologics Corp.|Vaccinex - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Perusahaan Nalika Diakuisisi Penuh Harpoon Therapeutics Inc (HARP)